# Reagent Resource Support Program for AIDS Vaccine Development

> **NIH NIH N01** · QUALITY BIOLOGICAL, INC. · 2024 · $3,261,511

## Abstract

The discovery and development of an HIV/AIDS vaccine remains among the highest research priorities of the National Institute of Allergy and Infectious Diseases (NIAID), and is a principal mission of NIAID’s Division of AIDS (DAIDS).  To support this mission, NIAID has provided high-quality, novel, and targeted reagents, assays and services for investigators engaged in AIDS vaccine-related research, including NIAID-funded grantees and contractors, other NIH-funded researchers, and investigators supported through various Non-Governmental Organizations (NGOs). These services are provided through this contract by investigator request and NIAID staff approval.

## Key facts

- **NIH application ID:** 11055264
- **Project number:** 272201800007C-P00016-9999-1
- **Recipient organization:** QUALITY BIOLOGICAL, INC.
- **Principal Investigator:** VALERIE FREMONT
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,261,511
- **Award type:** —
- **Project period:** 2018-04-08 → 2025-04-07

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11055264

## Citation

> US National Institutes of Health, RePORTER application 11055264, Reagent Resource Support Program for AIDS Vaccine Development (272201800007C-P00016-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/11055264. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*